{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T23:23:16Z","timestamp":1791415396819,"version":"4.3.3"},"reference-count":99,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biomed"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Synovial hyperplasia is the main cause of chronic rheumatoid arthritis (RA), but the mechanism of synovial hyperplasia is still unclear. Etodolac (ETD) is a selective COX-2 inhibitor for relieving pain and stiffness in RA, but the disease modifying effect is still lack of evidence. Proteomics method was used to study the differential proteome of synovial tissue in collagen induced arthritis (CIA) in rats. With the help of STRING analysis, the upregulated proteins enriched in the cluster of complement and coagulation cascades and platelet degranulation were highlighted, these proteins with fibrogenic factors Lum, CIV, CXI and Tgfbi participated in the synovial inflammation, fibrosis and hyperplasia in CIA. Based on KOG function class analysis, the proteins involved in the events of the central dogma was explored. They might be hyperplasia related proteins for most of them are related to the proliferation of cancer. ETD significantly attenuated synovial inflammation, fibrosis and hyperplasia in CIA rats by downregulating these proteins. Several proteins have not been observed in RA so far, such as Tmsb4x, Pura, Nfic, Ruvbl1, Snrpd3, U2af2, Srrm2, Srsf7, Elavl1, Hnrnph1, Wars, Yars, Bzw2, Mcts1, Eif4b, Ctsh, Lamp1, Dpp7, Ptges3, Cdc37 and Septin9, they might be potentials targets for RA. Blood biochemistry tests showed the safety of 7\u2009months use of ETD on rats. In conclusion, present study displayed a comprehensive mechanism of synovial hyperplasia in CIA rats, on this basis, the clinical value of ETD in the treatment of RA was well confirmed.<\/jats:p>","DOI":"10.1186\/s43556-021-00052-1","type":"journal-article","created":{"date-parts":[[2021,10,24]],"date-time":"2021-10-24T20:02:22Z","timestamp":1635105742000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Etodolac improves collagen induced rheumatoid arthritis in rats by inhibiting synovial inflammation, fibrosis and hyperplasia"],"prefix":"10.1186","volume":"2","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0808-7385","authenticated-orcid":false,"given":"Qin","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkai","family":"Xia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shenglan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoxin","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weimei","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Na","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honghua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guimin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,25]]},"reference":[{"issue":"10086","key":"52_CR1","doi-asserted-by":"publisher","first-page":"2328","DOI":"10.1016\/S0140-6736(17)31472-1","volume":"389","author":"IB McInnes","year":"2017","unstructured":"McInnes IB, Schett G. Pathogenetic insights from the treatment of rheumatoid arthritis. Lancet. 2017;389(10086):2328\u201337 https:\/\/doi.org\/10.1016\/S0140-6736(17)31472-1.","journal-title":"Lancet."},{"issue":"7","key":"52_CR2","doi-asserted-by":"publisher","first-page":"10018","DOI":"10.1002\/jcp.27860","volume":"234","author":"M Abbasi","year":"2019","unstructured":"Abbasi M, Mousavi MJ, Jamalzehi S, Alimohammadi R, Bezvan MH, Mohammadi H, et al. Strategies toward rheumatoid arthritis therapy; the old and the new. J Cell Physiol. 2019;234(7):10018\u201331 https:\/\/doi.org\/10.1002\/jcp.27860.","journal-title":"J Cell Physiol"},{"issue":"11","key":"52_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta12110","volume":"12","author":"YF Chen","year":"2008","unstructured":"Chen YF, Jobanputra P, Barton P, Bryan S, Fry-Smith A, Harris G, et al. Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation. Health Technol Assess. 2008;12(11):1\u2013iii https:\/\/doi.org\/10.3310\/hta12110.","journal-title":"Health Technol Assess"},{"issue":"10","key":"52_CR4","doi-asserted-by":"publisher","first-page":"19705","DOI":"10.3390\/ijms141019705","volume":"14","author":"K Kumagai","year":"2013","unstructured":"Kumagai K, Kubo M, Imai S, Toyoda F, Maeda T, Okumura N, et al. The COX-2 selective blocker etodolac inhibits TNF\u03b1-induced apoptosis in isolated rabbit articular chondrocytes. Int J Mol Sci. 2013;14(10):19705\u201315 https:\/\/doi.org\/10.3390\/ijms141019705.","journal-title":"Int J Mol Sci"},{"key":"52_CR5","first-page":"40","volume":"47","author":"DM Dvornik","year":"1997","unstructured":"Dvornik DM. Tissue selective inhibition of prostaglandin biosynthesis by etodolac. J Rheumatol Suppl. 1997;47:40\u20137.","journal-title":"J Rheumatol Suppl."},{"issue":"2","key":"52_CR6","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1159\/000069536","volume":"68","author":"M Tachibana","year":"2003","unstructured":"Tachibana M, Inoue N, Yoshida E, Matsui M, Ukai Y, Yano J. Anti-inflammatory effect and low ulcerogenic activity of etodolac, a cyclooxygenase-2 selective non-steroidal anti-inflammatory drug, on adjuvant-induced arthritis in rats. Pharmacology. 2003;68(2):96\u2013104 https:\/\/doi.org\/10.1159\/000069536.","journal-title":"Pharmacology."},{"issue":"Suppl 1","key":"52_CR7","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1007\/BF02214109","volume":"8","author":"N Zvaifler","year":"1989","unstructured":"Zvaifler N. A review of the antiarthritic efficacy and safety of etodolac. Clin Rheumatol. 1989;8(Suppl 1):43\u201353 https:\/\/doi.org\/10.1007\/BF02214109.","journal-title":"Clin Rheumatol"},{"issue":"3","key":"52_CR8","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s10787-999-0010-3","volume":"7","author":"RA Jones","year":"1999","unstructured":"Jones RA. Etodolac: an overview of a selective COX-2 inhibitor. Inflammopharmacology. 1999;7(3):269\u201375 https:\/\/doi.org\/10.1007\/s10787-999-0010-3.","journal-title":"Inflammopharmacology."},{"issue":"6","key":"52_CR9","doi-asserted-by":"publisher","first-page":"1515","DOI":"10.1007\/s00404-011-1883-0","volume":"284","author":"K Hasegawa","year":"2011","unstructured":"Hasegawa K, Torii Y, Ishii R, Oe S, Kato R, Udagawa Y. Effects of a selective COX-2 inhibitor in patients with uterine endometrial cancers. Arch Gynecol Obstet. 2011;284(6):1515\u201321 https:\/\/doi.org\/10.1007\/s00404-011-1883-0.","journal-title":"Arch Gynecol Obstet"},{"issue":"2","key":"52_CR10","first-page":"357","volume":"17","author":"T Ishizaki","year":"2006","unstructured":"Ishizaki T, Katsumata K, Tsuchida A, Wada T, Mori Y, Hisada M, et al. Etodolac, a selective cyclooxygenase-2 inhibitor, inhibits liver metastasis of colorectal cancer cells via the suppression of MMP-9 activity. Int J Mol Med. 2006;17(2):357\u201362.","journal-title":"Int J Mol Med"},{"issue":"2","key":"52_CR11","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1021\/acs.jproteome.6b00727","volume":"16","author":"EN Nigjeh","year":"2017","unstructured":"Nigjeh EN, Chen R, Brand RE, Petersen GM, Chari ST, von Haller PD, et al. Quantitative proteomics based on optimized data-independent Acquisition in Plasma Analysis. J Proteome Res. 2017;16(2):665\u201376 https:\/\/doi.org\/10.1021\/acs.jproteome.6b00727.","journal-title":"J Proteome Res"},{"issue":"11","key":"52_CR12","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1074\/mcp.O112.020131","volume":"11","author":"AC Peterson","year":"2012","unstructured":"Peterson AC, Russell JD, Bailey DJ, Westphall MS, Coon JJ. Parallel reaction monitoring for high resolution and high mass accuracy quantitative, targeted proteomics. Mol Cell Proteomics. 2012;11(11):1475\u201388 https:\/\/doi.org\/10.1074\/mcp.O112.020131.","journal-title":"Mol Cell Proteomics"},{"issue":"1","key":"52_CR13","doi-asserted-by":"publisher","first-page":"248","DOI":"10.1021\/acs.jproteome.9b00511","volume":"19","author":"ARM Silva","year":"2020","unstructured":"Silva ARM, Toyoshima MTK, Passarelli M, Di Mascio P, Ronsein GE. Comparing data-independent acquisition and parallel reaction monitoring in their abilities to differentiate high-density lipoprotein subclasses. J Proteome Res. 2020;19(1):248\u201359 https:\/\/doi.org\/10.1021\/acs.jproteome.9b00511.","journal-title":"J Proteome Res"},{"issue":"4","key":"52_CR14","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1136\/ard.48.4.302","volume":"48","author":"VA Makinde","year":"1989","unstructured":"Makinde VA, Senaldi G, Jawad AS, Berry H, Vergani D. Reflection of disease activity in rheumatoid arthritis by indices of activation of the classical complement pathway. Ann Rheum Dis. 1989;48(4):302\u20136 https:\/\/doi.org\/10.1136\/ard.48.4.302.","journal-title":"Ann Rheum Dis"},{"issue":"6","key":"52_CR15","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1186\/ar2089","volume":"8","author":"KS Nandakumar","year":"2006","unstructured":"Nandakumar KS, Holmdahl R. Antibody-induced arthritis: disease mechanisms and genes involved at the effector phase of arthritis. Arthritis Res Ther. 2006;8(6):223 https:\/\/doi.org\/10.1186\/ar2089.","journal-title":"Arthritis Res Ther."},{"issue":"2","key":"52_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.bbagen.2016.11.023","volume":"1861","author":"N Roy","year":"2017","unstructured":"Roy N, Ohtani K, Hidaka Y, Amano Y, Matsuda Y, Mori K, et al. Three pentraxins C-reactive protein, serum amyloid p component and pentraxin 3 mediate complement activation using Collectin CL-P1. Biochim Biophys Acta Gen Subj. 2017;1861(2):1\u201314 https:\/\/doi.org\/10.1016\/j.bbagen.2016.11.023.","journal-title":"Biochim Biophys Acta Gen Subj"},{"issue":"7","key":"52_CR17","doi-asserted-by":"publisher","first-page":"3365","DOI":"10.4049\/jimmunol.1500493","volume":"195","author":"YJ Ma","year":"2015","unstructured":"Ma YJ, Hein E, Munthe-Fog L, Skjoedt MO, Bayarri-Olmos R, Romani L, et al. Soluble Collectin-12 (CL-12) is a pattern recognition molecule initiating complement activation via the alternative pathway. J Immunol. 2015;195(7):3365\u201373 https:\/\/doi.org\/10.4049\/jimmunol.1500493.","journal-title":"J Immunol"},{"issue":"10","key":"52_CR18","doi-asserted-by":"publisher","first-page":"2779","DOI":"10.4049\/jimmunol.1900372","volume":"204","author":"LM Vogt","year":"2020","unstructured":"Vogt LM, Kwasniewicz E, Talens S, Scavenius C, Bielecka E, Ekdahl KN, et al. Apolipoprotein E triggers complement activation in joint synovial fluid of rheumatoid arthritis patients by binding C1q. J Immunol. 2020;204(10):2779\u201390 https:\/\/doi.org\/10.4049\/jimmunol.1900372.","journal-title":"J Immunol"},{"issue":"2","key":"52_CR19","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1159\/000484257","volume":"10","author":"S Irmscher","year":"2018","unstructured":"Irmscher S, D\u00f6ring N, Halder LD, Jo EAH, Kopka I, Dunker C, et al. Kallikrein cleaves C3 and activates complement. J Innate Immun. 2018;10(2):94\u2013105 https:\/\/doi.org\/10.1159\/000484257.","journal-title":"J Innate Immun"},{"issue":"6","key":"52_CR20","doi-asserted-by":"publisher","first-page":"457","DOI":"10.1016\/0952-3278(94)90065-5","volume":"51","author":"K Inoue","year":"1994","unstructured":"Inoue K, Motonaga A, Dainaka J, Unger A, Sommerfeld L, Jansen JM, et al. Effect of etodolac on prostaglandin E2 biosynthesis, active oxygen generation and bradykinin formation. Prostaglandins Leukot Essent Fatty Acids. 1994;51(6):457\u201362 https:\/\/doi.org\/10.1016\/0952-3278(94)90065-5.","journal-title":"Prostaglandins Leukot Essent Fatty Acids"},{"issue":"3","key":"52_CR21","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1160\/TH13-03-0258","volume":"110","author":"J Bj\u00f6rkqvist","year":"2013","unstructured":"Bj\u00f6rkqvist J, J\u00e4ms\u00e4 A, Renn\u00e9 T. Plasma kallikrein: the bradykinin-producing enzyme. Thromb Haemost. 2013;110(3):399\u2013407 https:\/\/doi.org\/10.1160\/TH13-03-0258.","journal-title":"Thromb Haemost"},{"key":"52_CR22","doi-asserted-by":"crossref","unstructured":"Luyendyk JP, Schoenecker JG, Flick MJ. The multifaceted role of fibrinogen in tissue injury and inflammation. Blood. 2019;133(6):511\u2013520. https:\/\/doi.org\/10.1182\/blood-2018-07-818211.","DOI":"10.1182\/blood-2018-07-818211"},{"issue":"3","key":"52_CR23","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1042\/EBC20180051","volume":"63","author":"B Piersma","year":"2019","unstructured":"Piersma B, Bank RA. Collagen cross-linking mediated by lysyl hydroxylase 2: an enzymatic battlefield to combat fibrosis. Essays Biochem. 2019;63(3):377\u201387 https:\/\/doi.org\/10.1042\/EBC20180051.","journal-title":"Essays Biochem"},{"issue":"11","key":"52_CR24","doi-asserted-by":"publisher","first-page":"1954","DOI":"10.1093\/rheumatology\/kev228","volume":"54","author":"DF Remst","year":"2015","unstructured":"Remst DF, Blaney Davidson EN, van der Kraan PM. Unravelling osteoarthritis-related synovial fibrosis: a step closer to solving joint stiffness. Rheumatology (Oxford). 2015;54(11):1954\u201363 https:\/\/doi.org\/10.1093\/rheumatology\/kev228.","journal-title":"Rheumatology (Oxford)"},{"issue":"1","key":"52_CR25","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1517\/14712598.2012.634793","volume":"12","author":"AL Goldstein","year":"2012","unstructured":"Goldstein AL, Hannappel E, Sosne G, Kleinman HK. Thymosin \u03b24: a multi-functional regenerative peptide. Basic properties and clinical applications. Expert Opin Biol Ther. 2012;12(1):37\u201351 https:\/\/doi.org\/10.1517\/14712598.2012.634793.","journal-title":"Expert Opin Biol Ther"},{"key":"52_CR26","doi-asserted-by":"publisher","first-page":"9037197","DOI":"10.1155\/2019\/9037197","volume":"2019","author":"Y Chu","year":"2019","unstructured":"Chu Y, You M, Zhang J, Gao G, Han R, Luo W, et al. Adipose-derived mesenchymal stem cells enhance ovarian Cancer growth and metastasis by increasing Thymosin Beta 4X-linked expression. Stem Cells Int. 2019;2019:9037197. https:\/\/doi.org\/10.1155\/2019\/9037197\u20139.","journal-title":"Stem Cells Int"},{"issue":"5","key":"52_CR27","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1161\/CIRCGENETICS.110.957795","volume":"4","author":"S Franklin","year":"2011","unstructured":"Franklin S, Vondriska TM. Genomes, proteomes, and the central dogma. Circ Cardiovasc Genet. 2011;4(5):576 https:\/\/doi.org\/10.1161\/CIRCGENETICS.110.957795.","journal-title":"Circ Cardiovasc Genet"},{"issue":"1","key":"52_CR28","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1016\/j.bcp.2014.04.012","volume":"90","author":"C Zhao","year":"2014","unstructured":"Zhao C, Hui W, Fernandes MJ, Poubelle PE, Bourgoin SG. Lysophosphatidic acid-induced IL-8 secretion involves MSK1 and MSK2 mediated activation of CREB1 in human fibroblast-like synoviocytes. Biochem Pharmacol. 2014;90(1):62\u201372 https:\/\/doi.org\/10.1016\/j.bcp.2014.04.012.","journal-title":"Biochem Pharmacol"},{"issue":"6","key":"52_CR29","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41419-019-1650-x","volume":"10","author":"Y Li","year":"2019","unstructured":"Li Y, Fu Y, Hu X, Sun L, Tang D, Li N, et al. The HBx-CTTN interaction promotes cell proliferation and migration of hepatocellular carcinoma via CREB1. Cell Death Dis. 2019;10(6):405 https:\/\/doi.org\/10.1038\/s41419-019-1650-x.","journal-title":"Cell Death Dis"},{"issue":"12","key":"52_CR30","doi-asserted-by":"publisher","first-page":"1926","DOI":"10.4161\/cbt.7.12.6938","volume":"7","author":"R Kaminski","year":"2008","unstructured":"Kaminski R, Darbinyan A, Merabova N, Deshmane SL, White MK, Khalili K. Protective role of Puralpha to cisplatin. Cancer Biol Ther. 2008;7(12):1926\u201335 https:\/\/doi.org\/10.4161\/cbt.7.12.6938.","journal-title":"Cancer Biol Ther"},{"issue":"1","key":"52_CR31","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1186\/s12935-020-01207-w","volume":"20","author":"G Xu","year":"2020","unstructured":"Xu G, Zhang Y, Li N, Wu Y, Zhang J, Xu R, et al. LBX2-AS1 up-regulated by NFIC boosts cell proliferation, migration and invasion in gastric cancer through targeting miR-491-5p\/ZNF703. Cancer Cell Int. 2020;20(1):136. https:\/\/doi.org\/10.1186\/s12935-020-01207-w.","journal-title":"Cancer Cell Int"},{"issue":"6","key":"52_CR32","doi-asserted-by":"publisher","first-page":"2132","DOI":"10.1074\/jbc.M116.753251","volume":"292","author":"J Zhang","year":"2017","unstructured":"Zhang J, Jiang HY, Zhang LK, Xu WL, Qiao YT, Zhu XG, et al. C-FLIPL modulated Wnt\/\u03b2-catenin activation via association with TIP49 protein. J Biol Chem. 2017;292(6):2132\u201342 https:\/\/doi.org\/10.1074\/jbc.M116.753251.","journal-title":"J Biol Chem"},{"issue":"10","key":"52_CR33","doi-asserted-by":"publisher","first-page":"1866","DOI":"10.1136\/annrheumdis-2015-208356","volume":"75","author":"E Corsiero","year":"2016","unstructured":"Corsiero E, Bombardieri M, Carlotti E, Pratesi F, Robinson W, Migliorini P, et al. Single cell cloning and recombinant monoclonal antibodies generation from RA synovial B cells reveal frequent targeting of citrullinated histones of NETs. Ann Rheum Dis. 2016;75(10):1866\u201375 https:\/\/doi.org\/10.1136\/annrheumdis-2015-208356.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"52_CR34","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/nrg.2016.93","volume":"17","author":"PA Jones","year":"2016","unstructured":"Jones PA, Issa JP, Baylin S. Targeting the cancer epigenome for therapy. Nat Rev Genet. 2016;17(10):630\u201341 https:\/\/doi.org\/10.1038\/nrg.2016.93.","journal-title":"Nat Rev Genet"},{"issue":"2","key":"52_CR35","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1111\/j.1365-2249.1991.tb08156.x","volume":"84","author":"KL Zuklys","year":"1991","unstructured":"Zuklys KL, Szer IS, Szer W. Autoantibodies to DNA topoisomerase II in juvenile rheumatoid arthritis. Clin Exp Immunol. 1991;84(2):245\u20139 https:\/\/doi.org\/10.1111\/j.1365-2249.1991.tb08156.x.","journal-title":"Clin Exp Immunol"},{"issue":"31","key":"52_CR36","doi-asserted-by":"publisher","first-page":"4019","DOI":"10.1038\/onc.2014.332","volume":"34","author":"T Chen","year":"2015","unstructured":"Chen T, Sun Y, Ji P, Kopetz S, Zhang W. Topoisomerase II\u03b1 in chromosome instability and personalized cancer therapy. Oncogene. 2015;34(31):4019\u201331 https:\/\/doi.org\/10.1038\/onc.2014.332.","journal-title":"Oncogene."},{"issue":"5","key":"52_CR37","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1002\/1878-0261.12052","volume":"11","author":"E Siebring-van Olst","year":"2017","unstructured":"Siebring-van Olst E, Blijlevens M, de Menezes RX, van der Meulen-Muileman IH, Smit EF, van Beusechem VW. A genome-wide siRNA screen for regulators of tumor suppressor p53 activity in human non-small cell lung cancer cells identifies components of the RNA splicing machinery as targets for anticancer treatment. Mol Oncol. 2017;11(5):534\u201351 https:\/\/doi.org\/10.1002\/1878-0261.12052.","journal-title":"Mol Oncol"},{"issue":"1","key":"52_CR38","doi-asserted-by":"publisher","first-page":"709","DOI":"10.4049\/jimmunol.172.1.709","volume":"172","author":"EL Greidinger","year":"2004","unstructured":"Greidinger EL, Foecking MF, Magee J, Wilson L, Ranatunga S, Ortmann RA, et al. A major B cell epitope present on the apoptotic but not the intact form of the U1-70-kDa ribonucleoprotein autoantigen. J Immunol. 2004;172(1):709\u201316 https:\/\/doi.org\/10.4049\/jimmunol.172.1.709.","journal-title":"J Immunol"},{"issue":"3","key":"52_CR39","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1155\/2011\/583182","volume":"34","author":"WE Pierceall","year":"2011","unstructured":"Pierceall WE, Wolfe M, Suschak J, Chang H, Chen Y, Sprott KM, et al. Strategies for H-score normalization of preanalytical technical variables with potential utility to immunohistochemical-based biomarker quantitation in therapeutic response diagnostics. Anal Cell Pathol (Amst). 2011;34(3):159\u201368 https:\/\/doi.org\/10.3233\/ACP-2011-014.","journal-title":"Anal Cell Pathol (Amst)"},{"issue":"1","key":"52_CR40","doi-asserted-by":"publisher","first-page":"179","DOI":"10.7150\/thno.29545","volume":"9","author":"J Li","year":"2019","unstructured":"Li J, Cheng D, Zhu M, Yu H, Pan Z, Liu L, et al. OTUB2 stabilizes U2AF2 to promote the Warburg effect and tumorigenesis via the AKT\/mTOR signaling pathway in non-small cell lung cancer. Theranostics. 2019;9(1):179\u201395 https:\/\/doi.org\/10.7150\/thno.29545.","journal-title":"Theranostics."},{"issue":"11","key":"52_CR41","doi-asserted-by":"publisher","first-page":"7757","DOI":"10.1002\/jcp.29382","volume":"235","author":"S Chen","year":"2020","unstructured":"Chen S, Lv L, Zhan Z, Wang X, You Z, Luo X, et al. Silencing of long noncoding RNA SRRM2-AS exerts suppressive effects on angiogenesis in nasopharyngeal carcinoma via activating MYLK-mediated cGMP-PKG signaling pathway. J Cell Physiol. 2020;235(11):7757\u201368 https:\/\/doi.org\/10.1002\/jcp.29382.","journal-title":"J Cell Physiol"},{"issue":"4","key":"52_CR42","doi-asserted-by":"publisher","first-page":"5545","DOI":"10.3892\/ol.2018.8072","volume":"15","author":"Y Fu","year":"2018","unstructured":"Fu Y, Wang Y. SRSF7 knockdown promotes apoptosis of colon and lung cancer cells. Oncol Lett. 2018;15(4):5545\u201352 https:\/\/doi.org\/10.3892\/ol.2018.8072.","journal-title":"Oncol Lett"},{"issue":"2","key":"52_CR43","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1002\/wrna.4","volume":"1","author":"K Abdelmohsen","year":"2010","unstructured":"Abdelmohsen K, Gorospe M. Posttranscriptional regulation of cancer traits by HuR. Wiley Interdiscip Rev RNA. 2010;1(2):214\u201329 https:\/\/doi.org\/10.1002\/wrna.4.","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"52_CR44","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.53557","volume":"9","author":"E Monz\u00f3n-Casanova","year":"2020","unstructured":"Monz\u00f3n-Casanova E, Matheson LS, Tabbada K, Zarnack K, Smith CW, Turner M. Polypyrimidine tract-binding proteins are essential for B cell development. Elife. 2020;9:e53557 https:\/\/doi.org\/10.7554\/eLife.53557.","journal-title":"Elife."},{"issue":"3","key":"52_CR45","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1038\/s41590-017-0035-5","volume":"19","author":"E Monz\u00f3n-Casanova","year":"2018","unstructured":"Monz\u00f3n-Casanova E, Screen M, D\u00edaz-Mu\u00f1oz MD, Coulson RMR, Bell SE, Lamers G, et al. The RNA-binding protein PTBP1 is necessary for B cell selection in germinal centers. Nat Immunol. 2018;19(3):267\u201378 https:\/\/doi.org\/10.1038\/s41590-017-0035-5.","journal-title":"Nat Immunol"},{"key":"52_CR46","doi-asserted-by":"publisher","unstructured":"Georgilis A, Klotz S, Hanley CJ, Herranz N, Weirich B, Morancho B, et al. PTBP1-Mediated Alternative Splicing Regulates the Inflammatory Secretome and the Pro-tumorigenic Effects of Senescent Cells. Cancer Cell. 2018;34(1):85\u2013102.e9. https:\/\/doi.org\/10.1016\/j.ccell.2018.06.007.","DOI":"10.1016\/j.ccell.2018.06.007"},{"issue":"5","key":"52_CR47","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1182\/blood.2019002385","volume":"136","author":"P Pararajalingam","year":"2020","unstructured":"Pararajalingam P, Coyle KM, Arthur SE, Thomas N, Alcaide M, Meissner B, et al. Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing. Blood. 2020;136(5):572\u201384 https:\/\/doi.org\/10.1182\/blood.2019002385.","journal-title":"Blood."},{"issue":"3","key":"52_CR48","doi-asserted-by":"publisher","first-page":"1002","DOI":"10.1073\/pnas.1313768111","volume":"111","author":"Z Li","year":"2014","unstructured":"Li Z, Chao TC, Chang KY, Lin N, Patil VS, Shimizu C, et al. The long noncoding RNA THRIL regulates TNF\u03b1 expression through its interaction with hnRNPL. Proc Natl Acad Sci U S A. 2014;111(3):1002\u20137 https:\/\/doi.org\/10.1073\/pnas.1313768111.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"26","key":"52_CR49","doi-asserted-by":"publisher","first-page":"E5207","DOI":"10.1073\/pnas.1617467114","volume":"114","author":"T Fei","year":"2017","unstructured":"Fei T, Chen Y, Xiao T, Fei T, Chen Y, Xiao T, et al. Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing. Proc Natl Acad Sci U S A. 2017;114(26):E5207\u201315 https:\/\/doi.org\/10.1073\/pnas.1617467114.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"52_CR50","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1080\/09168451.2019.1686967","volume":"84","author":"PP Yang","year":"2020","unstructured":"Yang PP, Yu XH, Zhou J. Tryptophanyl-tRNA synthetase (WARS) expression in uveal melanoma - possible contributor during uveal melanoma progression. Biosci Biotechnol Biochem. 2020;84(3):471\u201380 https:\/\/doi.org\/10.1080\/09168451.2019.1686967.","journal-title":"Biosci Biotechnol Biochem"},{"issue":"2","key":"52_CR51","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1007\/s00432-019-03115-7","volume":"146","author":"C Zhang","year":"2020","unstructured":"Zhang C, Lin X, Zhao Q, Wang Y, Jiang F, Ji C, et al. YARS as an oncogenic protein that promotes gastric cancer progression through activating PI3K-Akt signaling. J Cancer Res Clin Oncol. 2020;146(2):329\u201342 https:\/\/doi.org\/10.1007\/s00432-019-03115-7.","journal-title":"J Cancer Res Clin Oncol"},{"issue":"5","key":"52_CR52","doi-asserted-by":"publisher","first-page":"4834","DOI":"10.1002\/jcp.29361","volume":"235","author":"L Huang","year":"2020","unstructured":"Huang L, Chen S, Fan H, Ai F, Sheng W. BZW2 promotes the malignant progression of colorectal cancer via activating the ERK\/MAPK pathway. J Cell Physiol. 2020;235(5):4834\u201342 https:\/\/doi.org\/10.1002\/jcp.29361.","journal-title":"J Cell Physiol"},{"issue":"4","key":"52_CR53","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1093\/abbs\/gmy021","volume":"50","author":"G Chang","year":"2018","unstructured":"Chang G, Zheng J, Xiao W, Chang S, Wei Q, Wu H, et al. PKC inhibition of sotrastaurin has antitumor activity in diffuse large B-cell lymphoma via regulating the expression of MCT-1. Acta Biochim Biophys Sin Shanghai. 2018;50(4):399\u2013407 https:\/\/doi.org\/10.1093\/abbs\/gmy021.","journal-title":"Acta Biochim Biophys Sin Shanghai"},{"issue":"14","key":"52_CR54","doi-asserted-by":"publisher","first-page":"2923","DOI":"10.1111\/j.1432-1033.2004.04217.x","volume":"271","author":"G Hern\u00e1ndez","year":"2004","unstructured":"Hern\u00e1ndez G, V\u00e1zquez-Pianzola P, Zurbriggen A, Altmann M, Sierra JM, Rivera-Pomar R. Two functionally redundant isoforms of Drosophila melanogaster eukaryotic initiation factor 4B are involved in cap-dependent translation, cell survival, and proliferation. Eur J Biochem. 2004;271(14):2923\u201336 https:\/\/doi.org\/10.1111\/j.1432-1033.2004.04217.x.","journal-title":"Eur J Biochem"},{"issue":"3","key":"52_CR55","doi-asserted-by":"publisher","first-page":"4467","DOI":"10.3892\/mmr.2018.8429","volume":"17","author":"B Mi","year":"2018","unstructured":"Mi B, Liu G, Zhou W, Lv H, Liu Y, Liu J. Identification of genes and pathways in the synovia of women with osteoarthritis by bioinformatics analysis. Mol Med Rep. 2018;17(3):4467\u201373 https:\/\/doi.org\/10.3892\/mmr.2018.8429.","journal-title":"Mol Med Rep"},{"key":"52_CR56","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.bcp.2018.11.014","volume":"159","author":"F Catez","year":"2019","unstructured":"Catez F, Dalla Venezia N, Marcel V, Zorbas C, Lafontaine DLJ, Diaz JJ. Ribosome biogenesis: an emerging druggable pathway for cancer therapeutics. Biochem Pharmacol. 2019;159:74\u201381 https:\/\/doi.org\/10.1016\/j.bcp.2018.11.014.","journal-title":"Biochem Pharmacol"},{"issue":"11","key":"52_CR57","doi-asserted-by":"publisher","first-page":"9623","DOI":"10.1074\/jbc.M110.177436","volume":"286","author":"H Hou","year":"2011","unstructured":"Hou H, Wang F, Zhang W, Wang D, Li X, Bartlam M, et al. Structure-functional analyses of CRHSP-24 plasticity and dynamics in oxidative stress response. J Biol Chem. 2011;286(11):9623\u201335 https:\/\/doi.org\/10.1074\/jbc.M110.177436.","journal-title":"J Biol Chem"},{"key":"52_CR58","doi-asserted-by":"publisher","unstructured":"Tiwari R, Sahu I, Soni BL, Sathe GJ, Datta KK, Thapa P, et al. Quantitative phosphoproteomic analysis reveals system-wide signaling pathways regulated by site-specific phosphorylation of Keratin-8 in skin squamous cell carcinoma derived cell line. Proteomics. 2017;17(7):https:\/\/doi.org\/10.1002\/pmic.201600254.","DOI":"10.1002\/pmic.201600254"},{"issue":"1","key":"52_CR59","doi-asserted-by":"publisher","first-page":"R3","DOI":"10.1186\/ar2587","volume":"11","author":"M Katano","year":"2009","unstructured":"Katano M, Okamoto K, Arito M, Kawakami Y, Kurokawa MS, Suematsu N, et al. Implication of granulocyte-macrophage colony-stimulating factor induced neutrophil gelatinase-associated lipocalin in pathogenesis of rheumatoid arthritis revealed by proteome analysis. Arthritis Res Ther. 2009;11(1):R3 https:\/\/doi.org\/10.1186\/ar2587.","journal-title":"Arthritis Res Ther."},{"issue":"1","key":"52_CR60","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s40425-019-0498-z","volume":"7","author":"Y Ashraf","year":"2019","unstructured":"Ashraf Y, Mansouri H, Laurent-Matha V, Alcaraz LB, Roger P, Guiu S, et al. Immunotherapy of triple-negative breast cancer with cathepsin D-targeting antibodies. J Immunother Cancer. 2019;7(1):29 https:\/\/doi.org\/10.1186\/s40425-019-0498-z.","journal-title":"J Immunother Cancer"},{"issue":"4","key":"52_CR61","doi-asserted-by":"publisher","first-page":"2201","DOI":"10.1074\/jbc.M112.436394","volume":"288","author":"Z Jevnikar","year":"2013","unstructured":"Jevnikar Z, Rojnik M, Jamnik P, Doljak B, Fonovic UP, Kos J. Cathepsin H mediates the processing of Talin and regulates migration of prostate cancer cells. J Biol Chem. 2013;288(4):2201\u20139 https:\/\/doi.org\/10.1074\/jbc.M112.436394.","journal-title":"J Biol Chem"},{"issue":"4","key":"52_CR62","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1053\/j.seminoncol.2017.10.013","volume":"44","author":"F Alessandrini","year":"2017","unstructured":"Alessandrini F, Pezz\u00e8 L, Ciribilli Y. LAMPs: shedding light on cancer biology. Semin Oncol. 2017;44(4):239\u201353 https:\/\/doi.org\/10.1053\/j.seminoncol.2017.10.013.","journal-title":"Semin Oncol"},{"issue":"7","key":"52_CR63","doi-asserted-by":"publisher","first-page":"1527","DOI":"10.3390\/cancers13071527","volume":"13","author":"JJ Miettinen","year":"2021","unstructured":"Miettinen JJ, Kumari R, Traustadottir GA, Huppunen ME, Sergeev P, Majumder MM, et al. Aminopeptidase expression in multiple myeloma associates with disease progression and sensitivity to Melflufen. Cancers (Basel). 2021;13(7):1527 https:\/\/doi.org\/10.3390\/cancers13071527.","journal-title":"Cancers (Basel)"},{"issue":"1","key":"52_CR64","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1186\/s13075-015-0529-1","volume":"17","author":"SE Verbrugge","year":"2015","unstructured":"Verbrugge SE, Scheper RJ, Lems WF, de Gruijl TD, Jansen G. Proteasome inhibitors as experimental therapeutics of autoimmune diseases. Arthritis Res Ther. 2015;17(1):17 https:\/\/doi.org\/10.1186\/s13075-015-0529-1.","journal-title":"Arthritis Res Ther."},{"issue":"28","key":"52_CR65","doi-asserted-by":"publisher","first-page":"24733","DOI":"10.18632\/oncotarget.4619","volume":"6","author":"TA Grigoreva","year":"2015","unstructured":"Grigoreva TA, Tribulovich VG, Garabadzhiu AV, Melino G, Barlev NA. The 26S proteasome is a multifaceted target for anti-cancer therapies. Oncotarget. 2015;6(28):24733\u201349 https:\/\/doi.org\/10.18632\/oncotarget.4619.","journal-title":"Oncotarget."},{"issue":"3","key":"52_CR66","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1089\/dna.1992.11.221","volume":"11","author":"PA Chorazy","year":"1992","unstructured":"Chorazy PA, Schumacher HR Jr, Edlind TD. Role of glutathione peroxidase in rheumatoid arthritis: analysis of enzyme activity and DNA polymorphism. DNA Cell Biol. 1992;11(3):221\u20135 https:\/\/doi.org\/10.1089\/dna.1992.11.221.","journal-title":"DNA Cell Biol"},{"issue":"4","key":"52_CR67","doi-asserted-by":"publisher","first-page":"124","DOI":"10.21037\/atm.2020.02.36","volume":"8","author":"R Wei","year":"2020","unstructured":"Wei R, Qiu H, Xu J, Mo J, Liu Y, Gui Y, et al. Expression and prognostic potential of GPX1 in human cancers based on data mining. Ann Transl Med. 2020;8(4):124 https:\/\/doi.org\/10.21037\/atm.2020.02.36.","journal-title":"Ann Transl Med"},{"issue":"6","key":"52_CR68","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1007\/s12192-020-01114-z","volume":"25","author":"S Tukaj","year":"2020","unstructured":"Tukaj S, Mantej J, Sobala M, Potrykus K, Sitko K. Autologous extracellular Hsp70 exerts a dual role in rheumatoid arthritis. Cell Stress Chaperones. 2020;25(6):1105\u201310 https:\/\/doi.org\/10.1007\/s12192-020-01114-z.","journal-title":"Cell Stress Chaperones"},{"issue":"1","key":"52_CR69","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.canlet.2016.01.056","volume":"374","author":"S Kumar","year":"2016","unstructured":"Kumar S, Stokes J 3rd, Singh UP, Scissum Gunn K, Acharya A, Manne U, et al. Targeting Hsp70: a possible therapy for cancer. Cancer Lett. 2016;374(1):156\u201366 https:\/\/doi.org\/10.1016\/j.canlet.2016.01.056.","journal-title":"Cancer Lett"},{"issue":"5","key":"52_CR70","doi-asserted-by":"publisher","first-page":"354","DOI":"10.3109\/03009742.2011.552522","volume":"40","author":"L Sedlackova","year":"2011","unstructured":"Sedlackova L, Sosna A, Vavrincova P, Fr\u00fddl J, Guerriero V, Raynes DA, et al. Heat shock protein gene expression profile may differentiate between rheumatoid arthritis, osteoarthritis, and healthy controls. Scand J Rheumatol. 2011;40(5):354\u20137 https:\/\/doi.org\/10.3109\/03009742.2011.552522.","journal-title":"Scand J Rheumatol"},{"issue":"4","key":"52_CR71","doi-asserted-by":"publisher","first-page":"423","DOI":"10.2174\/13894501113146660230","volume":"15","author":"J Acunzo","year":"2014","unstructured":"Acunzo J, Andrieu C, Baylot V, So A, Rocchi P. Hsp27 as a therapeutic target in cancers. Curr Drug Targets. 2014;15(4):423\u201331 https:\/\/doi.org\/10.2174\/13894501113146660230.","journal-title":"Curr Drug Targets"},{"issue":"11","key":"52_CR72","doi-asserted-by":"publisher","first-page":"19064","DOI":"10.1002\/jcb.29229","volume":"120","author":"S Bharadwaj","year":"2019","unstructured":"Bharadwaj S, Lee KE, Dwivedi VD, Yadava U, Kang SG. Computational aided mechanistic understanding of Camellia sinensis bioactive compounds against co-chaperone p23 as potential anticancer agent. J Cell Biochem. 2019;120(11):19064\u201375 https:\/\/doi.org\/10.1002\/jcb.29229.","journal-title":"J Cell Biochem"},{"issue":"3","key":"52_CR73","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1111\/cas.13495","volume":"109","author":"J Zhu","year":"2018","unstructured":"Zhu J, Yan F, Tao J, Zhu X, Liu J, Deng S, et al. Cdc37 facilitates cell survival of colorectal carcinoma via activating the CDK4 signaling pathway. Cancer Sci. 2018;109(3):656\u201365 https:\/\/doi.org\/10.1111\/cas.13495.","journal-title":"Cancer Sci"},{"issue":"2","key":"52_CR74","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1515\/hsz-2013-0247","volume":"395","author":"D Connolly","year":"2014","unstructured":"Connolly D, Hoang HG, Adler E, Tazearslan C, Simmons N, Bernard VV, et al. Septin 9 amplification and isoform-specific expression in peritumoral and tumor breast tissue. Biol Chem. 2014;395(2):157\u201367 https:\/\/doi.org\/10.1515\/hsz-2013-0247.","journal-title":"Biol Chem"},{"issue":"30","key":"52_CR75","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.1038\/s41388-019-0844-0","volume":"38","author":"J Marcus","year":"2019","unstructured":"Marcus J, Bejerano-Sagie M, Patterson N. Agchi S, Verkhusha VV, Connolly D, et al. Septin 9 isoforms promote tumorigenesis in mammary epithelial cells by increasing migration and ECM degradation through metalloproteinase secretion at focal adhesions. Oncogene. 2019;38(30):5839\u201359 https:\/\/doi.org\/10.1038\/s41388-019-0844-0.","journal-title":"Oncogene."},{"issue":"1","key":"52_CR76","first-page":"23","volume":"14","author":"EM Veys","year":"1994","unstructured":"Veys EM. Clinical performance of etodolac in patients with osteoarthritis and rheumatoid arthritis. Eur J Rheumatol Inflamm. 1994;14(1):23\u20137.","journal-title":"Eur J Rheumatol Inflamm"},{"key":"52_CR77","first-page":"10","volume":"47","author":"R Lightfoot","year":"1997","unstructured":"Lightfoot R. Comparison of the efficacy and safety of etodolac and piroxicam in patients with rheumatoid arthritis. Etodolac study 326 rheumatoid arthritis investigators group. J Rheumatol Suppl. 1997;47:10\u20136.","journal-title":"J Rheumatol Suppl"},{"key":"52_CR78","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.3389\/fimmu.2018.01057","volume":"9","author":"VM Holers","year":"2018","unstructured":"Holers VM, Banda NK. Complement in the initiation and evolution of rheumatoid arthritis. Front Immunol. 2018;9:1057 https:\/\/doi.org\/10.3389\/fimmu.2018.01057.","journal-title":"Front Immunol"},{"issue":"10055","key":"52_CR79","doi-asserted-by":"publisher","first-page":"2023","DOI":"10.1016\/S0140-6736(16)30173-8","volume":"388","author":"JS Smolen","year":"2016","unstructured":"Smolen JS, Aletaha D, McInnes IB. Rheumatoid arthritis [published correction appears in lancet. 2016 Oct 22;388(10055):1984]. Lancet. 2016;388(10055):2023\u201338 https:\/\/doi.org\/10.1016\/S0140-6736(16)30173-8.","journal-title":"Lancet."},{"issue":"12","key":"52_CR80","doi-asserted-by":"publisher","first-page":"738","DOI":"10.1038\/nrrheum.2012.184","volume":"8","author":"B Hoppe","year":"2012","unstructured":"Hoppe B, D\u00f6rner T. Coagulation and the fibrin network in rheumatic disease: a role beyond haemostasis. Nat Rev Rheumatol. 2012;8(12):738\u201346 https:\/\/doi.org\/10.1038\/nrrheum.2012.184.","journal-title":"Nat Rev Rheumatol"},{"issue":"4","key":"52_CR81","doi-asserted-by":"publisher","first-page":"F471","DOI":"10.1152\/ajprenal.00189.2014","volume":"307","author":"FL Craciun","year":"2014","unstructured":"Craciun FL, Ajay AK, Hoffmann D, Saikumar J, Fabian SL, Bijol V, et al. Pharmacological and genetic depletion of fibrinogen protects from kidney fibrosis. Am J Physiol Renal Physiol. 2014;307(4):F471\u201384 https:\/\/doi.org\/10.1152\/ajprenal.00189.2014.","journal-title":"Am J Physiol Renal Physiol"},{"key":"52_CR82","doi-asserted-by":"publisher","first-page":"2871289","DOI":"10.1155\/2019\/2871289","volume":"2019","author":"Y Wang","year":"2019","unstructured":"Wang Y, Sun Y, Feng J, Li Z, Yu H, Ding X, et al. Glycopatterns and glycoproteins changes in MCN and SCN: a prospective cohort study. Biomed Res Int. 2019;2019:2871289. https:\/\/doi.org\/10.1155\/2019\/2871289\u201311.","journal-title":"Biomed Res Int"},{"issue":"1","key":"52_CR83","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1038\/s41594-018-0171-0","volume":"26","author":"YH Chen","year":"2019","unstructured":"Chen YH, Keegan S, Kahli M, Tonzi P, Feny\u00f6 D, Huang TT, et al. Transcription shapes DNA replication initiation and termination in human cells. Nat Struct Mol Biol. 2019;26(1):67\u201377 https:\/\/doi.org\/10.1038\/s41594-018-0171-0.","journal-title":"Nat Struct Mol Biol"},{"issue":"10","key":"52_CR84","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrg2164","volume":"8","author":"GS Wang","year":"2007","unstructured":"Wang GS, Cooper TA. Splicing in disease: disruption of the splicing code and the decoding machinery. Nat Rev Genet. 2007;8(10):749\u201361 https:\/\/doi.org\/10.1038\/nrg2164.","journal-title":"Nat Rev Genet."},{"key":"52_CR85","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.3389\/fimmu.2018.01094","volume":"9","author":"MD D\u00edaz-Mu\u00f1oz","year":"2018","unstructured":"D\u00edaz-Mu\u00f1oz MD, Turner M. Uncovering the role of RNA-binding proteins in gene expression in the immune system. Front Immunol. 2018;9:1094 https:\/\/doi.org\/10.3389\/fimmu.2018.01094.","journal-title":"Front Immunol"},{"issue":"9","key":"52_CR86","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1038\/nm.4165","volume":"22","author":"SC Lee","year":"2016","unstructured":"Lee SC, Abdel-Wahab O. Therapeutic targeting of splicing in cancer. Nat Med. 2016;22(9):976\u201386 https:\/\/doi.org\/10.1038\/nm.4165.","journal-title":"Nat Med"},{"issue":"12","key":"52_CR87","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/s41573-019-0036-1","volume":"18","author":"SR Bonam","year":"2019","unstructured":"Bonam SR, Wang F, Muller S. Lysosomes as a therapeutic target. Nat Rev Drug Discov. 2019;18(12):923\u201348 https:\/\/doi.org\/10.1038\/s41573-019-0036-1.","journal-title":"Nat Rev Drug Discov"},{"issue":"5","key":"52_CR88","doi-asserted-by":"publisher","first-page":"865","DOI":"10.1515\/BC.2002.093","volume":"383","author":"N Sohar","year":"2002","unstructured":"Sohar N, Hammer H, Sohar I. Lysosomal peptidases and glycosidases in rheumatoid arthritis. Biol Chem. 2002;383(5):865\u20139 https:\/\/doi.org\/10.1515\/BC.2002.093.","journal-title":"Biol Chem"},{"issue":"6","key":"52_CR89","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1016\/j.apsb.2015.08.001","volume":"5","author":"M Siklos","year":"2015","unstructured":"Siklos M, BenAissa M, Thatcher GR. Cysteine proteases as therapeutic targets: does selectivity matter? A systematic review of calpain and cathepsin inhibitors. Acta Pharm Sin B. 2015;5(6):506\u201319 https:\/\/doi.org\/10.1016\/j.apsb.2015.08.001.","journal-title":"Acta Pharm Sin B"},{"issue":"8","key":"52_CR90","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.ctrv.2005.10.001","volume":"31","author":"G Jackson","year":"2005","unstructured":"Jackson G, Einsele H, Moreau P, Miguel JS. Bortezomib, a novel proteasome inhibitor, in the treatment of hematologic malignancies. Cancer Treat Rev. 2005;31(8):591\u2013602 https:\/\/doi.org\/10.1016\/j.ctrv.2005.10.001.","journal-title":"Cancer Treat Rev"},{"key":"52_CR91","doi-asserted-by":"publisher","unstructured":"Wang L, Zhang L, Li L, Zheng Z, Shang J, Wang C, et al. Small-molecule inhibitor targeting the Hsp90-Cdc37 protein-protein interaction in colorectal cancer. Sci Adv. 2019;5(9):eaax2277. https:\/\/doi.org\/10.1126\/sciadv.aax2277","DOI":"10.1126\/sciadv.aax2277"},{"issue":"2","key":"52_CR92","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1379\/CSC-99r.1","volume":"10","author":"DR Ciocca","year":"2005","unstructured":"Ciocca DR, Calderwood SK. Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones. 2005;10(2):86\u2013103 https:\/\/doi.org\/10.1379\/csc-99r.1.","journal-title":"Cell Stress Chaperones"},{"issue":"3","key":"52_CR93","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.tips.2016.11.009","volume":"38","author":"J Wu","year":"2017","unstructured":"Wu J, Liu T, Rios Z, Mei Q, Lin X, Cao S. Heat shock proteins and Cancer. Trends Pharmacol Sci. 2017;38(3):226\u201356 https:\/\/doi.org\/10.1016\/j.tips.2016.11.009.","journal-title":"Trends Pharmacol Sci"},{"issue":"1","key":"52_CR94","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1186\/s13075-017-1303-3","volume":"19","author":"MF Bustamante","year":"2017","unstructured":"Bustamante MF, Garcia-Carbonell R, Whisenant KD, Guma M. Fibroblast-like synoviocyte metabolism in the pathogenesis of rheumatoid arthritis. Arthritis Res Ther. 2017;19(1):110 https:\/\/doi.org\/10.1186\/s13075-017-1303-3.","journal-title":"Arthritis Res Ther"},{"issue":"7","key":"52_CR95","doi-asserted-by":"publisher","first-page":"918","DOI":"10.2174\/1381612822666151209153535","volume":"22","author":"OO Olumuyiwa-Akeredolu","year":"2016","unstructured":"Olumuyiwa-Akeredolu OO, Pretorius E. Rheumatoid arthritis: notable biomarkers linking to chronic systemic conditions and Cancer. Curr Pharm Des. 2016;22(7):918\u201324 https:\/\/doi.org\/10.2174\/1381612822666151209153535.","journal-title":"Curr Pharm Des"},{"issue":"5","key":"52_CR96","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1002\/hon.2525","volume":"36","author":"A Klein","year":"2018","unstructured":"Klein A, Polliack A, Gafter-Gvili A. Rheumatoid arthritis and lymphoma: incidence, pathogenesis, biology, and outcome. Hematol Oncol. 2018;36(5):733\u20139 https:\/\/doi.org\/10.1002\/hon.2525.","journal-title":"Hematol Oncol"},{"issue":"3","key":"52_CR97","first-page":"471","volume":"36","author":"HW Tseng","year":"2018","unstructured":"Tseng HW, Lu LY, Lam HC, Tsai KW, Huang WC, Shiue YL. The influence of disease-modifying anti-rheumatic drugs and corticosteroids on the association between rheumatoid arthritis and skin cancer: a nationwide retrospective case-control study in Taiwan. Clin Exp Rheumatol. 2018;36(3):471\u20138.","journal-title":"Clin Exp Rheumatol"},{"issue":"9","key":"52_CR98","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2217\/fon-2019-0722","volume":"16","author":"S Morand","year":"2020","unstructured":"Morand S, Staats H, Creeden JF, Iqbal A, Kahaleh B, Stanbery L, et al. Molecular mechanisms underlying rheumatoid arthritis and cancer development and treatment. Future Oncol. 2020;16(9):483\u201395 https:\/\/doi.org\/10.2217\/fon-2019-0722.","journal-title":"Future Oncol"},{"issue":"5","key":"52_CR99","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1078\/0344-0338-5710261","volume":"198","author":"V Krenn","year":"2002","unstructured":"Krenn V, Morawietz L, H\u00e4upl T, Neidel J, Petersen I, K\u00f6nig A. Grading of chronic synovitis--a histopathological grading system for molecular and diagnostic pathology. Pathol Res Pract. 2002;198(5):317\u201325 https:\/\/doi.org\/10.1078\/0344-0338-5710261.","journal-title":"Pathol Res Pract"}],"container-title":["Molecular Biomedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-021-00052-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s43556-021-00052-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s43556-021-00052-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,2,7]],"date-time":"2023-02-07T11:05:44Z","timestamp":1675767944000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s43556-021-00052-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,25]]},"references-count":99,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["52"],"URL":"https:\/\/doi.org\/10.1186\/s43556-021-00052-1","relation":{},"ISSN":["2662-8651"],"issn-type":[{"value":"2662-8651","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,25]]},"assertion":[{"value":"16 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was carried out according to the National Institutes of Health Guidelines for the Care and Use of Laboratory Animals and was approved by the Animal Care and Use Committee of Shandong Province, China.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All authors give consent for the publication of manuscript in Molecular Biomedicine.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All the authors of this paper are employees of Lunan Pharmaceutical Group, the research funds are provided by Lunan pharmaceutical Group.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"33"}}